The charts of the maker of medical devices for monitoring diabetes suggest a pause in its shares may be ahead.
The Fed did a great job in boosting the asset markets with its aggressive monetary stimulus; now we need to see real economic growth.
Huge earnings news and economic reports will drive the indices while aggressive speculative trading continues in smaller stocks.
The Fed has done a lot, and is willing to do even more, but for now, is watching Congress. The fiscal side is where the next shoe falls.
More than anything else, the hearings shine a light on how tech giants are looking to defend themselves as antitrust probes continue.
Breadth and the down-and-outers keep pulling us in and then dribbling away.
There are two distinct elements of this market and my choice is easy.
Let me disabuse you of some of the biggest canards that people routinely spout involving the Fed and stocks.
It's a good time to check the WORK charts again.
Let's check out some charts and indicators and see where CSGP may be headed.